Source | Evidence on protein | Close homologs |
---|---|---|
Cuervo et al. | no | yes: 0 |
Hassani et al. | no | yes: 0 |
Forrest at al. (metacyclic) | no | yes: 0 |
Forrest at al. (procyclic) | no | yes: 0 |
Silverman et al. | no | yes: 0 |
Pissara et al. | no | yes: 0 |
Source | Evidence on protein | Close homologs |
---|---|---|
Pires et al. | no | yes: 0 |
Source | Evidence on protein | Close homologs |
---|---|---|
Silverman et al. | no | yes: 0 |
Source | Evidence on protein | Close homologs |
---|---|---|
Jamdhade et al. | no | yes: 0 |
Source | Evidence on protein | Close homologs |
---|---|---|
DeepLoc | ||
SignalP6 | no | yes: 0, no: 12 |
NetGPI | no | yes: 0, no: 12 |
Term | Name | Level | Count |
---|---|---|---|
GO:0005829 | cytosol | 2 | 1 |
GO:0110165 | cellular anatomical entity | 1 | 1 |
Related structures:
AlphaFold database: E9ALQ4
Term | Name | Level | Count |
---|---|---|---|
GO:0006082 | organic acid metabolic process | 3 | 1 |
GO:0006139 | nucleobase-containing compound metabolic process | 3 | 1 |
GO:0006163 | purine nucleotide metabolic process | 5 | 1 |
GO:0006629 | lipid metabolic process | 3 | 1 |
GO:0006631 | fatty acid metabolic process | 4 | 1 |
GO:0006637 | acyl-CoA metabolic process | 4 | 1 |
GO:0006725 | cellular aromatic compound metabolic process | 3 | 1 |
GO:0006753 | nucleoside phosphate metabolic process | 4 | 1 |
GO:0006790 | sulfur compound metabolic process | 3 | 1 |
GO:0006793 | phosphorus metabolic process | 3 | 1 |
GO:0006796 | phosphate-containing compound metabolic process | 4 | 1 |
GO:0006807 | nitrogen compound metabolic process | 2 | 1 |
GO:0008152 | metabolic process | 1 | 1 |
GO:0009117 | nucleotide metabolic process | 5 | 1 |
GO:0009150 | purine ribonucleotide metabolic process | 6 | 1 |
GO:0009259 | ribonucleotide metabolic process | 5 | 1 |
GO:0009987 | cellular process | 1 | 1 |
GO:0019637 | organophosphate metabolic process | 3 | 1 |
GO:0019693 | ribose phosphate metabolic process | 4 | 1 |
GO:0019752 | carboxylic acid metabolic process | 5 | 1 |
GO:0032787 | monocarboxylic acid metabolic process | 6 | 1 |
GO:0033865 | nucleoside bisphosphate metabolic process | 5 | 1 |
GO:0033875 | ribonucleoside bisphosphate metabolic process | 6 | 1 |
GO:0034032 | purine nucleoside bisphosphate metabolic process | 5 | 1 |
GO:0034641 | cellular nitrogen compound metabolic process | 3 | 1 |
GO:0035383 | thioester metabolic process | 3 | 1 |
GO:0043436 | oxoacid metabolic process | 4 | 1 |
GO:0043603 | amide metabolic process | 3 | 1 |
GO:0044237 | cellular metabolic process | 2 | 1 |
GO:0044238 | primary metabolic process | 2 | 1 |
GO:0044255 | cellular lipid metabolic process | 3 | 1 |
GO:0044281 | small molecule metabolic process | 2 | 1 |
GO:0046483 | heterocycle metabolic process | 3 | 1 |
GO:0055086 | nucleobase-containing small molecule metabolic process | 3 | 1 |
GO:0071704 | organic substance metabolic process | 2 | 1 |
GO:0072521 | purine-containing compound metabolic process | 4 | 1 |
GO:1901135 | carbohydrate derivative metabolic process | 3 | 1 |
GO:1901360 | organic cyclic compound metabolic process | 3 | 1 |
GO:1901564 | organonitrogen compound metabolic process | 3 | 1 |
Term | Name | Level | Count |
---|---|---|---|
GO:0003824 | catalytic activity | 1 | 13 |
GO:0016787 | hydrolase activity | 2 | 13 |
GO:0016788 | hydrolase activity, acting on ester bonds | 3 | 13 |
GO:0016790 | thiolester hydrolase activity | 4 | 13 |
GO:0000062 | fatty-acyl-CoA binding | 4 | 1 |
GO:0000166 | nucleotide binding | 3 | 4 |
GO:0005488 | binding | 1 | 4 |
GO:0008289 | lipid binding | 2 | 1 |
GO:0016289 | CoA hydrolase activity | 5 | 1 |
GO:0017076 | purine nucleotide binding | 4 | 4 |
GO:0030554 | adenyl nucleotide binding | 5 | 4 |
GO:0032553 | ribonucleotide binding | 3 | 4 |
GO:0032555 | purine ribonucleotide binding | 4 | 4 |
GO:0032559 | adenyl ribonucleotide binding | 5 | 4 |
GO:0033218 | amide binding | 2 | 1 |
GO:0036042 | long-chain fatty acyl-CoA binding | 5 | 1 |
GO:0036094 | small molecule binding | 2 | 4 |
GO:0047617 | acyl-CoA hydrolase activity | 6 | 1 |
GO:0097159 | organic cyclic compound binding | 2 | 4 |
GO:0097367 | carbohydrate derivative binding | 2 | 4 |
GO:0120227 | acyl-CoA binding | 3 | 1 |
GO:1901265 | nucleoside phosphate binding | 3 | 4 |
GO:1901363 | heterocyclic compound binding | 2 | 4 |
GO:1901567 | fatty acid derivative binding | 3 | 1 |
GO:1901681 | sulfur compound binding | 2 | 1 |
GO:0005524 | ATP binding | 5 | 3 |
GO:0035639 | purine ribonucleoside triphosphate binding | 4 | 3 |
GO:0043167 | ion binding | 2 | 3 |
GO:0043168 | anion binding | 3 | 3 |
Leishmania | From | To | Domain/Motif | Score |
---|---|---|---|---|
CLV_C14_Caspase3-7 | 237 | 241 | PF00656 | 0.220 |
CLV_NRD_NRD_1 | 196 | 198 | PF00675 | 0.523 |
CLV_NRD_NRD_1 | 3 | 5 | PF00675 | 0.464 |
CLV_NRD_NRD_1 | 325 | 327 | PF00675 | 0.432 |
CLV_NRD_NRD_1 | 347 | 349 | PF00675 | 0.524 |
CLV_NRD_NRD_1 | 382 | 384 | PF00675 | 0.553 |
CLV_PCSK_FUR_1 | 210 | 214 | PF00082 | 0.591 |
CLV_PCSK_KEX2_1 | 212 | 214 | PF00082 | 0.585 |
CLV_PCSK_KEX2_1 | 3 | 5 | PF00082 | 0.464 |
CLV_PCSK_KEX2_1 | 382 | 384 | PF00082 | 0.509 |
CLV_PCSK_PC1ET2_1 | 212 | 214 | PF00082 | 0.574 |
CLV_PCSK_SKI1_1 | 100 | 104 | PF00082 | 0.448 |
CLV_PCSK_SKI1_1 | 171 | 175 | PF00082 | 0.429 |
CLV_PCSK_SKI1_1 | 213 | 217 | PF00082 | 0.458 |
CLV_PCSK_SKI1_1 | 243 | 247 | PF00082 | 0.443 |
CLV_PCSK_SKI1_1 | 274 | 278 | PF00082 | 0.375 |
CLV_PCSK_SKI1_1 | 280 | 284 | PF00082 | 0.310 |
DEG_MDM2_SWIB_1 | 297 | 304 | PF02201 | 0.344 |
DEG_Nend_Nbox_1 | 1 | 3 | PF02207 | 0.493 |
DOC_CKS1_1 | 113 | 118 | PF01111 | 0.230 |
DOC_CYCLIN_yCln2_LP_2 | 181 | 187 | PF00134 | 0.484 |
DOC_MAPK_gen_1 | 171 | 181 | PF00069 | 0.404 |
DOC_MAPK_gen_1 | 348 | 356 | PF00069 | 0.454 |
DOC_MAPK_HePTP_8 | 346 | 358 | PF00069 | 0.496 |
DOC_MAPK_MEF2A_6 | 312 | 320 | PF00069 | 0.285 |
DOC_MAPK_MEF2A_6 | 348 | 356 | PF00069 | 0.441 |
DOC_MAPK_RevD_3 | 185 | 198 | PF00069 | 0.414 |
DOC_PP1_RVXF_1 | 241 | 247 | PF00149 | 0.507 |
DOC_PP4_FxxP_1 | 113 | 116 | PF00568 | 0.372 |
DOC_PP4_FxxP_1 | 292 | 295 | PF00568 | 0.272 |
DOC_USP7_MATH_1 | 156 | 160 | PF00917 | 0.423 |
DOC_USP7_MATH_1 | 83 | 87 | PF00917 | 0.471 |
DOC_USP7_MATH_1 | 9 | 13 | PF00917 | 0.619 |
DOC_USP7_UBL2_3 | 191 | 195 | PF12436 | 0.391 |
DOC_USP7_UBL2_3 | 323 | 327 | PF12436 | 0.390 |
DOC_WW_Pin1_4 | 112 | 117 | PF00397 | 0.425 |
DOC_WW_Pin1_4 | 144 | 149 | PF00397 | 0.420 |
DOC_WW_Pin1_4 | 164 | 169 | PF00397 | 0.413 |
DOC_WW_Pin1_4 | 23 | 28 | PF00397 | 0.613 |
DOC_WW_Pin1_4 | 61 | 66 | PF00397 | 0.520 |
LIG_14-3-3_CanoR_1 | 100 | 108 | PF00244 | 0.429 |
LIG_14-3-3_CanoR_1 | 210 | 216 | PF00244 | 0.558 |
LIG_14-3-3_CanoR_1 | 312 | 317 | PF00244 | 0.292 |
LIG_14-3-3_CanoR_1 | 335 | 339 | PF00244 | 0.339 |
LIG_14-3-3_CanoR_1 | 375 | 381 | PF00244 | 0.430 |
LIG_14-3-3_CanoR_1 | 84 | 90 | PF00244 | 0.448 |
LIG_Actin_WH2_2 | 156 | 173 | PF00022 | 0.366 |
LIG_AP2alpha_2 | 183 | 185 | PF02296 | 0.400 |
LIG_BRCT_BRCA1_1 | 11 | 15 | PF00533 | 0.718 |
LIG_BRCT_BRCA1_1 | 288 | 292 | PF00533 | 0.344 |
LIG_CaM_IQ_9 | 196 | 212 | PF13499 | 0.553 |
LIG_FHA_1 | 101 | 107 | PF00498 | 0.373 |
LIG_FHA_1 | 113 | 119 | PF00498 | 0.410 |
LIG_FHA_1 | 150 | 156 | PF00498 | 0.407 |
LIG_FHA_1 | 165 | 171 | PF00498 | 0.446 |
LIG_FHA_1 | 215 | 221 | PF00498 | 0.581 |
LIG_FHA_1 | 297 | 303 | PF00498 | 0.320 |
LIG_FHA_1 | 313 | 319 | PF00498 | 0.278 |
LIG_FHA_1 | 327 | 333 | PF00498 | 0.399 |
LIG_FHA_1 | 34 | 40 | PF00498 | 0.465 |
LIG_FHA_1 | 349 | 355 | PF00498 | 0.453 |
LIG_FHA_1 | 9 | 15 | PF00498 | 0.537 |
LIG_FHA_2 | 148 | 154 | PF00498 | 0.453 |
LIG_FHA_2 | 214 | 220 | PF00498 | 0.442 |
LIG_FHA_2 | 235 | 241 | PF00498 | 0.463 |
LIG_FHA_2 | 312 | 318 | PF00498 | 0.306 |
LIG_FHA_2 | 360 | 366 | PF00498 | 0.425 |
LIG_LIR_Apic_2 | 111 | 116 | PF02991 | 0.422 |
LIG_LIR_Apic_2 | 289 | 295 | PF02991 | 0.287 |
LIG_LIR_Gen_1 | 159 | 168 | PF02991 | 0.350 |
LIG_LIR_Gen_1 | 298 | 309 | PF02991 | 0.320 |
LIG_LIR_Gen_1 | 337 | 346 | PF02991 | 0.328 |
LIG_LIR_Gen_1 | 54 | 59 | PF02991 | 0.419 |
LIG_LIR_Nem_3 | 159 | 164 | PF02991 | 0.385 |
LIG_LIR_Nem_3 | 298 | 304 | PF02991 | 0.330 |
LIG_LIR_Nem_3 | 337 | 341 | PF02991 | 0.325 |
LIG_LIR_Nem_3 | 54 | 58 | PF02991 | 0.427 |
LIG_PCNA_yPIPBox_3 | 363 | 375 | PF02747 | 0.465 |
LIG_PDZ_Class_1 | 393 | 398 | PF00595 | 0.636 |
LIG_Pex14_2 | 297 | 301 | PF04695 | 0.320 |
LIG_PTB_Apo_2 | 107 | 114 | PF02174 | 0.401 |
LIG_SH2_GRB2like | 249 | 252 | PF00017 | 0.238 |
LIG_SH2_PTP2 | 193 | 196 | PF00017 | 0.416 |
LIG_SH2_STAT5 | 101 | 104 | PF00017 | 0.476 |
LIG_SH2_STAT5 | 140 | 143 | PF00017 | 0.407 |
LIG_SH2_STAT5 | 193 | 196 | PF00017 | 0.430 |
LIG_SH2_STAT5 | 310 | 313 | PF00017 | 0.309 |
LIG_SH3_3 | 287 | 293 | PF00018 | 0.371 |
LIG_SUMO_SIM_anti_2 | 317 | 322 | PF11976 | 0.378 |
LIG_SUMO_SIM_par_1 | 162 | 167 | PF11976 | 0.384 |
LIG_SUMO_SIM_par_1 | 25 | 32 | PF11976 | 0.412 |
LIG_TRAF2_1 | 216 | 219 | PF00917 | 0.551 |
LIG_TRAF2_1 | 361 | 364 | PF00917 | 0.449 |
MOD_CDK_SPxxK_3 | 144 | 151 | PF00069 | 0.523 |
MOD_CDK_SPxxK_3 | 164 | 171 | PF00069 | 0.484 |
MOD_CDK_SPxxK_3 | 61 | 68 | PF00069 | 0.543 |
MOD_CK1_1 | 147 | 153 | PF00069 | 0.420 |
MOD_CK1_1 | 159 | 165 | PF00069 | 0.308 |
MOD_CK1_1 | 22 | 28 | PF00069 | 0.572 |
MOD_CK1_1 | 61 | 67 | PF00069 | 0.571 |
MOD_CK2_1 | 147 | 153 | PF00069 | 0.473 |
MOD_CK2_1 | 174 | 180 | PF00069 | 0.256 |
MOD_CK2_1 | 213 | 219 | PF00069 | 0.496 |
MOD_CK2_1 | 311 | 317 | PF00069 | 0.301 |
MOD_CK2_1 | 359 | 365 | PF00069 | 0.412 |
MOD_Cter_Amidation | 346 | 349 | PF01082 | 0.527 |
MOD_GlcNHglycan | 16 | 19 | PF01048 | 0.561 |
MOD_GlcNHglycan | 176 | 179 | PF01048 | 0.244 |
MOD_GSK3_1 | 102 | 109 | PF00069 | 0.379 |
MOD_GSK3_1 | 147 | 154 | PF00069 | 0.426 |
MOD_GSK3_1 | 19 | 26 | PF00069 | 0.516 |
MOD_GSK3_1 | 296 | 303 | PF00069 | 0.309 |
MOD_GSK3_1 | 326 | 333 | PF00069 | 0.403 |
MOD_GSK3_1 | 386 | 393 | PF00069 | 0.615 |
MOD_LATS_1 | 231 | 237 | PF00433 | 0.496 |
MOD_LATS_1 | 98 | 104 | PF00433 | 0.469 |
MOD_N-GLC_1 | 234 | 239 | PF02516 | 0.482 |
MOD_N-GLC_1 | 252 | 257 | PF02516 | 0.301 |
MOD_N-GLC_1 | 312 | 317 | PF02516 | 0.320 |
MOD_N-GLC_2 | 390 | 392 | PF02516 | 0.588 |
MOD_NEK2_1 | 102 | 107 | PF00069 | 0.381 |
MOD_NEK2_1 | 14 | 19 | PF00069 | 0.544 |
MOD_NEK2_1 | 211 | 216 | PF00069 | 0.558 |
MOD_NEK2_1 | 245 | 250 | PF00069 | 0.521 |
MOD_NEK2_1 | 304 | 309 | PF00069 | 0.414 |
MOD_NEK2_2 | 156 | 161 | PF00069 | 0.423 |
MOD_PIKK_1 | 359 | 365 | PF00454 | 0.463 |
MOD_PIKK_1 | 83 | 89 | PF00454 | 0.436 |
MOD_PKA_1 | 204 | 210 | PF00069 | 0.566 |
MOD_PKA_1 | 326 | 332 | PF00069 | 0.540 |
MOD_PKA_1 | 348 | 354 | PF00069 | 0.397 |
MOD_PKA_2 | 311 | 317 | PF00069 | 0.292 |
MOD_PKA_2 | 334 | 340 | PF00069 | 0.336 |
MOD_PKA_2 | 83 | 89 | PF00069 | 0.463 |
MOD_Plk_1 | 252 | 258 | PF00069 | 0.301 |
MOD_Plk_1 | 304 | 310 | PF00069 | 0.348 |
MOD_Plk_1 | 312 | 318 | PF00069 | 0.285 |
MOD_Plk_1 | 327 | 333 | PF00069 | 0.432 |
MOD_Plk_2-3 | 300 | 306 | PF00069 | 0.344 |
MOD_Plk_4 | 108 | 114 | PF00069 | 0.416 |
MOD_Plk_4 | 156 | 162 | PF00069 | 0.351 |
MOD_Plk_4 | 245 | 251 | PF00069 | 0.453 |
MOD_Plk_4 | 252 | 258 | PF00069 | 0.338 |
MOD_Plk_4 | 304 | 310 | PF00069 | 0.385 |
MOD_Plk_4 | 327 | 333 | PF00069 | 0.424 |
MOD_Plk_4 | 334 | 340 | PF00069 | 0.292 |
MOD_ProDKin_1 | 112 | 118 | PF00069 | 0.425 |
MOD_ProDKin_1 | 144 | 150 | PF00069 | 0.424 |
MOD_ProDKin_1 | 164 | 170 | PF00069 | 0.416 |
MOD_ProDKin_1 | 23 | 29 | PF00069 | 0.610 |
MOD_ProDKin_1 | 61 | 67 | PF00069 | 0.514 |
MOD_SUMO_for_1 | 322 | 325 | PF00179 | 0.390 |
MOD_SUMO_rev_2 | 319 | 329 | PF00179 | 0.383 |
TRG_DiLeu_BaEn_3 | 364 | 370 | PF01217 | 0.460 |
TRG_ENDOCYTIC_2 | 140 | 143 | PF00928 | 0.425 |
TRG_ENDOCYTIC_2 | 193 | 196 | PF00928 | 0.378 |
TRG_ER_diArg_1 | 2 | 4 | PF00400 | 0.457 |
TRG_ER_diArg_1 | 373 | 376 | PF00400 | 0.402 |
TRG_Pf-PMV_PEXEL_1 | 197 | 201 | PF00026 | 0.594 |
TRG_Pf-PMV_PEXEL_1 | 213 | 218 | PF00026 | 0.477 |
Protein | Taxonomy | Sequence identity | Coverage |
---|---|---|---|
A0A0N1I2C1 | Leptomonas seymouri | 33% | 88% |
A0A0N1PDQ1 | Leptomonas seymouri | 72% | 100% |
A0A0S4JR10 | Bodo saltans | 36% | 91% |
A0A1X0NZW0 | Trypanosomatidae | 56% | 100% |
A0A1X0P0I5 | Trypanosomatidae | 38% | 100% |
A0A3S7X2I7 | Leishmania donovani | 94% | 100% |
A0A422NEB6 | Trypanosoma rangeli | 36% | 100% |
A4HHI1 | Leishmania braziliensis | 87% | 100% |
A4I4M9 | Leishmania infantum | 94% | 100% |
C9ZLB7 | Trypanosoma brucei gambiense (strain MHOM/CI/86/DAL972) | 54% | 100% |
E9AE30 | Leishmania major | 93% | 100% |
Q8VHQ9 | Mus musculus | 22% | 67% |